Unitaid publishes CEPA report

Home > News Archive > Unitaid publishes CEPA report
20th April 2018
Unitaid, the international organisation that invests in new ways to prevent, diagnose and treat HIV/AIDS, tuberculosis and malaria has published CEPA's independent mid-term evaluation of the HIV self-testing project. The Self-Testing Africa (STAR) project aims to address key evidence gaps and catalyse the market for HIV self-testing (HIVST). The project has two phases:

self-testPhase I, from September 2015 to August 2017, for a total budget of US$23.7m, implemented in Malawi, Zambia and Zimbabwe by a consortium led by Population Services International (PSI) and including:
 - the London School of Hygiene and Tropical Medicine
 - the Liverpool School of Tropical Medicine
 - University College London
 - World Health Organization
 - & local research partners

Phase II (or the STAR Initiative), which builds on the foundation laid in Phase I and involves scaling up self-testing in the Phase I and additional southern African countries (South Africa, Swaziland and Lesotho). Phase II will be implemented from August 2017 to July 2020 and will be delivered by a new consortium, with additional grantees specifically for South Africa.

The purpose of CEPA's mid-term evaluation was to carry out an assessment of the programmatic implementation of Phase I. The evaluation framework is structured around three key dimensions of:

  • Relevance
  • Efficiency & effectiveness
  • Results & impact

The report is available to download

To find out more about the Global Health team’s backgrounds and experience, members’ biographies and case studies are available online. Alternatively, if you would like an initial conversation to see if CEPA may be the best firm to support you, please contact Richard Rodger by email or T. +44 (0)20 7269 0210